1.Kenyon, TA, Ridzon, R, Luskin-Hawk, R, et al.A nosocomial outbreak of multidrug-resistant tuberculosis. Ann Intern Med. In press.
2.Van Embden, JDA, Cave, MD, Crawford, JT, et al.Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993;31:406–409.
3.Stead, WW. Pathogenesis of a first episode of chronic pulmonary tuberculosis in man: recrudescence of residuals of the primary infection or exogenous reinfection? Am Rev Respir Dis 1967;95:729–745.
4.Centers for Disease Control and Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities, 1994. MMWR 1994;43(RR-13):1–132.
5.Small, PM, Shafer, RW, Hopewell, PC, et al.Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV disease. N Engl J Med 1993;328:1137–1144.
6.Selwyn, PA, Hartel, D, Lewis, VA, et al.A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989;230:545–550.
7.Daley, CL, Small, PM, Schecter, GF, et al.An outbreak of tuberculosis with accelerated progression among persons infected with the immunodeficiency virus. N Engl J Med 1992;326:231–235.
8.Centers for Disease Control. Management of persons exposed to multi-drug resistant tuberculosis. MMWR 1992;41(No. RR-11):61–71.
9.Centers for Disease Control and Prevention. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: a summary. MMWR 1995;44(RR-8):9–10.